Journal of Vascular and Interventional Radiology
Volume 20, Issue 2 , Pages 225-234 , February 2009

Laser Ablation of Liver Metastases from Colorectal Cancer with MR Thermometry: 5-Year Survival

Received 10 December 2007 ,Revised 17 October 2008 ,Accepted 20 October 2008.

References 

  1. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol. 1976;2:285–288
  2. Fong Y, Kemeny N, Paty P, Blumgart LH, Cohen AM. Treatment of colorectal cancer hepatic metastases. Semin Surg Oncol. 1996;12:219–252
  3. Steele G, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Ann Surg. 1989;210:127–138
  4. Scheele J, Stangl R, Altendorf-Hoffmann A. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery. 1991;110:13–29
  5. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759–766
  6. Vogl TJ, Mack MG, Müller PK, Straub R, Engelmann K, Eichler K. Interventional MR: interstitial therapy. Eur Radiol. 1999;9:1479–1487
  7. Mack MG, Straub R, Eichler K, Söllner O, Lehnert T, Vogl TJ. Breast cancer metastases in liver: laser-induced interstitial thermotherapy – local tumour control rate and survival data. Radiology. 2004;233:400–409
  8. Seifert JK, Junginger T. Prognostic factors for cryotherapy of colorectal liver metastases. Eur J Surg Oncol. 2004;30:34–40
  9. Gillams AR, Lees WR. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum. 2000;43:656–666
  10. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001;221:159–166
  11. de Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol. 2003;181:695–700
  12. Bleicher RJ, Allegra DP, Nora DT, Wood TF, Foshag LJ, Bilchik AJ. Radiofrequency ablation in 447 complex unresectable liver tumours: lessons learned. Ann Surg Oncol. 2003;10:52–58
  13. Lencioni R, Crocetti I, Cioni D, Della Pina C, Bartolozzi C. Percutaneous radiofrequency ablation of hepatic colorectal metastases – technique, indications, results, and new principle. Invest Radiol. 2004;39:689–697
  14. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226:441–451
  15. Jakobs TF, Hoffmann RT, Trumm C, Reiser MF, Helmberger TK. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients. Anticancer Res. 2006;26:671–680
  16. Kennedy JE, Wu F, ter Haar GR, et al. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics. 2004;42:931–935
  17. Wu F, Wang ZB, Chen WZ, et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology. 2005;235:659–667
  18. Bremer C, Kreft G, Filler T, Reimer P. Accuracy of non-enhanced MRI to monitor histological lesion size during laser-induced interstitial thermotherapy. Eur Radiol. 2002;12:237–244
  19. Vogl TJ. Laser-induced thermotherapy: do we really need MR thermometry?. Eur Radiol. 2002;12:5–6
  20. Permpongkosol S, Nico TL, Khurana H, et al. Thermal maps around two adjacent cryoprobes creating overlapping ablationson porcine liver, lung, and kidney. J Vasc Interv Radiol. 2007;18:283–287
  21. Wood BJ, Locklin JK, Viswanathan A, et al. Technologies for guidance of radiofrequency ablation in the mutimodality interventional suite of the future. J Vasc Interv Radiol. 2007;18:9–24
  22. Hänsler J, Frieser M, Tietz V, et al. Percutaneous radiofrequency ablation of liver tumors using multiple saline-perfused electrodes. J Vasc Interv Radiol. 2007;18:405–410
  23. Solazzo SA, Ahmed M, Liu Z, Hines-Peralta AU, Goldberg SN. High-Power generator for radiofrequency ablation: larger electrodes and pulsing algorithms in bovine ex-vivo and porcine in vivo setting. Radiology. 2007;242:743–750
  24. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2005;16:765–778
  25. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(suppl):S199–S202
  26. Greenway B. Hepatic metastases from colorectal cancer: resection or not. Br J Surg. 1988;75:513–519
  27. Steele G, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Ann Surg. 1989;210:127–138
  28. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–321
  29. Wanebo HJ, Glicksmann AS, Vezeridis M, et al. Patient selection for hepatic resection of colorectal metastases. Arch Surg. 1996;131:322–332
  30. Hughes K, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986;100:278–283
  31. Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg. 1992;216:439–496
  32. Nordlinger G, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Cancer. 1996;77:1254–1262
  33. Elias D, Cavalcanti A, Sabourin JC, et al. Resection of liver metastases from colorectal cancer: the real impact on surgical margin. Eur J Surg Oncol. 1998;24:174–179
  34. Adson MA. Resection of liver metastases – when is it worthwhile?. World J Surg. 1987;11:511–520
  35. Adam R, Avisar E, Ariche A, et al. Five year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases. Ann Surg Oncol. 2001;8:347–353
  36. Kohne CH, Van Cutsem E, Wils J, et al. Irinotecan improves the activity of the AIO regime in metastatic colorectal cancer: results of EORTC GI Group study 40986. Presented at the Annual Scientific Meeting of the American Society of Clinical Oncology 2004; May 30, 2004; Orlando, Florida.
  37. Tellez C, Benson AB, Lyster M, et al. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer. 1998;82:1250–1259
  38. Vogl TJ, Straub R, Eichler K, Sollner O, Mack MG. Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy—local tumour control rate and survival data. Radiology. 2004;230:450–458
  39. Vogl TJ, Straub R, Eichler K, Woitaschek D, Mack MG. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2520 lesions). Radiology. 2002;225:367–377
  40. RJ , Chen MY, Shen P, Levine EA. Complications from radiofrequency ablation of liver metastases. Am Surg. 2002;68:204–209
  41. Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol. 2004;14:2261–2267
  42. Puls R, Stroszczynski C, Rosenberg C, et al. Three-dimensional gradient-echo imaging for percutaneous MR-guided laser therapy of liver metastasis. J Magn Reson Imaging. 2007;25:1174–1178

 None of the authors have identified a conflict of interest.

PII: S1051-0443(08)00933-0

doi: 10.1016/j.jvir.2008.10.018

Journal of Vascular and Interventional Radiology
Volume 20, Issue 2 , Pages 225-234 , February 2009

Article Tools

* Image Usage & Resolution